FDA Inspection 1180878 — MassBiologics

MassBiologics — FEI 3003058218

The FDA completed an inspection of MassBiologics on September 1, 2022 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 1, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Boston, MA (United States)